Willard Street Family Dental in Burlington, Vermont

This article distills what rheumatologists recommend in 2025 for managing lupus, from time‑tested essentials like hydroxychloroquine and short courses of low‑dose steroids to steroid‑sparing immunosuppressants (mycophenolate, azathioprine, methotrexate), newer biologics (belimumab, anifrolumab), and kidney‑targeted options for lupus nephritis (mycophenolate, voclosporin). It explains how doctors use a treat‑to‑target approach—aiming for low disease activity, minimizing steroid exposure, and monitoring labs—to personalize therapy based on symptoms, organ involvement, pregnancy plans, and patient priorities. Readers will also find practical tips on sun protection, vaccinations, heart and bone health, mental well‑being, and building a care team, empowering patients and caregivers to have informed, confident conversations with their clinicians.